Locate Mesa buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Dr. Travis Clark Stiegler, D.O.
204 North Center Street
Mesa, AZ 85201
Main Tel: (480) 962-0868
|
|
Dr. Michel A. Sucher, M.D.
Community Bridges, Inc.
1855 W. Baseline Road, Suite 101
Mesa, AZ 85201
Main Tel: 480-990-3111
|
|
John S. Kingsley,
570 West Brown Road
Mesa, AZ 85201
Main Tel: (480) 344-2000
|
|
Daniel Kenneth Merrill, M.D.
570 West Brown
Mesa, AZ 85201
Main Tel: (480) 344-2000
|
|
Dana-Jean S. La Haie, M.D.
1440 South Country Club Drive
Suite #12
Mesa, AZ 85210
Main Tel: (480) 838-5550
|
|
Dr. Suzanne A. Sisley, M.D.
1220 South Alma School Road
Suite 206
Mesa, AZ 85210
Main Tel: 928-474-6617
|
|
Warren H. Tripp, Jr., M.D.
Future Family Medicine PLLC
1140 South San Jose, Suite B
Mesa, AZ 85202
Main Tel: (480) 833-1859
|
|
Amish S. Purohit, M.D.
Arizona Priority Care Plus
706 North McQueen Road, Suite 109
Gilbert, AZ 85233
Main Tel: (480) 800-6400
|
|
John S. Martin, M.D.
1501 North Gilbert Road
Suite 200
Gilbert, AZ 85234
Main Tel: (480) 728-4430
|
|
Dr. Joshua Adam Levy, D.O.
81 West Guadalupe Road
Suite 111
Gilbert, AZ 85233
Main Tel: (480) 366-4490
|
|
J. Carvel Jackson, D.O.
3048 E Baseline Road
suite 122
Mesa, AZ 85204
Main Tel: (480) 737-1955
|
Opioid Use Disorder and Medication Assistance
Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy. Buprenorphine based medications enjoy a proven track record of success in helping patients achieve long lasting stablization and elimination of Read More
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Nearly every U.S. family is affected by addiction with opioid use disorder rising significantly in the last 10 years. Despite this trend, a surprising number of individuals still do not have access to medication-assisted therapy.